Desmopressin Acetate Injection, Solution
Product Images NDC 25021-460

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Desmopressin Acetate (NDC 25021-460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Des04 0000 01)

Figure (Des04 0000 01)
Chemical structure of desmopressin acetate showing the peptide sequence including amino acids Tyr, Phe, Gln, Asn, Cys, Pro, D-Arg, Gly, and NH2, along with associated acetate and water molecules.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Des04 0003 02)

Package Label – Principal Display Panel – Vial Label (Des04 0003 02)
Desmopressin acetate injection label with 4 mcg per mL strength in a 1 mL single-dose vial for intravenous or subcutaneous use. The label states it is manufactured by Sagent Pharmaceuticals with an NDC of 25021-460-01 and includes a barcode, lot, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.